Latest Research on Trt And Exercise Performance: 2024-2025 Update

Medically reviewed by Dr. Sarah Chen, PharmD, BCPS

Explore the evidence-based connection between Testosterone Replacement Therapy (TRT) and mental health, including its effects on depression and anxiety.

# Latest Research on TRT and Exercise Performance: 2024-2025 Update

Introduction

Testosterone Replacement Therapy (TRT) is a medical treatment for men with low testosterone levels, a condition known as hypogonadism. While the physical benefits of TRT are well-documented, its impact on mental health is an area of growing interest and research. This guide provides a comprehensive, evidence-based overview of the relationship between TRT and mental health outcomes.

The Link Between Testosterone and Mental Health

Testosterone plays a crucial role in various bodily functions, including mood regulation. Low testosterone levels have been associated with a range of mental health issues, including depression, anxiety, and irritability. Research suggests that testosterone may influence the production of neurotransmitters like serotonin and dopamine, which are known to affect mood.

The neurobiological mechanisms underlying testosterone's influence on mental health are multifaceted. Testosterone receptors are widely distributed throughout the brain, particularly in areas associated with mood, cognition, and emotion, such as the hippocampus, amygdala, and prefrontal cortex [1]. By interacting with these receptors, testosterone can modulate neuronal activity and gene expression, influencing the synthesis and degradation of neurotransmitters. For instance, preclinical studies have shown that testosterone can increase serotonin transporter availability and dopamine receptor density, both of which are implicated in mood regulation [2]. Furthermore, testosterone has anti-inflammatory properties and can reduce oxidative stress in the brain, potentially mitigating neuroinflammation, which is increasingly recognized as a contributor to mood disorders [3].

TRT for Depression

Several studies have investigated the potential of TRT as a treatment for depression in men with low testosterone. A meta-analysis of 27 randomized controlled trials published in JAMA Psychiatry found that testosterone treatment was associated with a significant reduction in depressive symptoms compared to placebo. However, the effects were more pronounced in men with higher-dosage regimens.

| Study | Year | Sample Size | Key Findings |

| :--------------------------------------- | :--- | :---------- | :--------------------------------------------------------------------------- |

| Walther et al., JAMA Psychiatry | 2019 | 3,571 | Testosterone treatment significantly reduced depressive symptoms in men. |

| Seidman et al., Journal of Clinical Psychiatry | 2001 | 34 | TRT was effective in treating major depressive disorder in hypogonadal men. |

Further clinical evidence supports these findings. A systematic review and meta-analysis published in The Lancet Psychiatry in 2020, encompassing 27 placebo-controlled trials, concluded that testosterone supplementation significantly improved depressive symptoms in men with hypogonadism, with a moderate effect size [4]. The benefits were particularly evident in men with baseline testosterone levels below 10 nmol/L (288 ng/dL). While the exact mechanism is still under investigation, it is hypothesized that TRT may alleviate depressive symptoms by normalizing neurotransmitter levels, improving energy and libido, and reducing chronic fatigue often associated with low testosterone [5].

Practical Considerations for TRT in Depression

When considering TRT for depression in hypogonadal men, a thorough diagnostic workup is essential. This includes:

Baseline Testosterone Levels: Multiple morning measurements of total and free testosterone are crucial.

Depression Assessment: Standardized depression scales (e.g., PHQ-9, Hamilton Depression Rating Scale) should be used.

Exclusion of Other Causes: Other medical or psychiatric conditions contributing to depression must be ruled out.

Typical TRT Protocols for Depression (Example)

| Formulation | Starting Dose | Administration Frequency | Target Testosterone Levels |

| :--------------- | :------------------------------------------ | :----------------------- | :------------------------- |

| Testosterone Cypionate/Enanthate (Injectable) | 100-150 mg intramuscularly (IM) | Every 7-10 days | 400-700 ng/dL |

| Testosterone Gel (Topical) | 50-100 mg daily (applied to skin) | Daily | 400-700 ng/dL |

Note: Dosing must be individualized and adjusted based on clinical response and laboratory monitoring.

TRT for Anxiety

The relationship between testosterone and anxiety is more complex. Some studies suggest that low testosterone may contribute to anxiety, while others indicate that high levels of the hormone could also be a factor. A study published in the journal Psychoneuroendocrinology found that TRT reduced anxiety-like behavior in male rodents. However, more research is needed to fully understand the effects of TRT on anxiety in humans.

Human studies on TRT and anxiety have yielded mixed results. A randomized controlled trial published in the Journal of Clinical Endocrinology & Metabolism found that TRT significantly reduced self-reported anxiety scores in hypogonadal men after 12 months of treatment, especially in those with more severe baseline symptoms [6]. Conversely, other studies have reported no significant change or even an increase in anxiety in some individuals, particularly with supraphysiological testosterone levels [7]. This variability might be due to individual differences in androgen receptor sensitivity, baseline anxiety levels, and the specific anxiety subtype being investigated.

The neurobiological link between testosterone and anxiety may involve the gamma-aminobutyric acid (GABA) system, the primary inhibitory neurotransmitter system in the brain. Testosterone and its metabolites, such as allopregnanolone, can act as positive allosteric modulators of GABA-A receptors, potentially exerting an anxiolytic effect [8]. However, the precise balance required for optimal anxiolysis is not fully understood, and excessive testosterone may disrupt this delicate equilibrium in some individuals.

Cognitive Function and TRT

Beyond mood disorders, emerging research explores the impact of TRT on various aspects of cognitive function, which are often intertwined with mental well-being. Low testosterone has been linked to deficits in verbal memory, spatial ability, and executive function [9].

A systematic review published in Hormones and Behavior in 2021 highlighted that TRT might improve certain cognitive domains, particularly spatial memory and executive function, in hypogonadal men [10]. However, the effects appear to be modest and more pronounced in older men with lower baseline testosterone levels and significant cognitive impairment. The impact on healthy younger men or those with mild cognitive decline is less clear. Testosterone's neuroprotective effects, its role in neuronal plasticity, and its influence on cerebral blood flow are thought to contribute to these cognitive benefits [11].

Potential Mechanisms for Cognitive Improvement:

Neurogenesis and Synaptic Plasticity: Testosterone can promote the growth of new neurons and strengthen synaptic connections, particularly in the hippocampus, a region critical for memory [12].

Neurotransmitter Modulation: Influence on cholinergic and dopaminergic systems, which are vital for attention and executive function.

Reduction of Neuroinflammation: Anti-inflammatory actions that protect neuronal health.

Safety Considerations and Contraindications

While TRT offers potential mental health benefits, it is not without risks and contraindications. A thorough medical evaluation is paramount before initiating therapy.

Common Side Effects:

Erythrocytosis: Increase in red blood cell count, requiring monitoring and sometimes phlebotomy [13].

Acne and Oily Skin: Due to increased sebum production.

Sleep Apnea Exacerbation: May worsen pre-existing sleep apnea [14].

Gynecomastia: Breast tissue enlargement, often managed with aromatase inhibitors.

Prostate Issues: While TRT does not cause prostate cancer, it can accelerate the growth of pre-existing, undiagnosed prostate cancer. Regular prostate-specific antigen (PSA) monitoring and digital rectal exams are necessary [15].

Contraindications:

Prostate Cancer: Known or suspected prostate cancer.

Breast Cancer: Male breast cancer.

Untreated Severe Sleep Apnea: Should be treated before initiating TRT.

Uncontrolled Congestive Heart Failure: May worsen fluid retention.

Erythrocytosis: Baseline hematocrit >50%.

Planned Pregnancy: TRT can suppress spermatogenesis and cause infertility [16].

Monitoring Protocol:

Regular monitoring is crucial to ensure safety and optimize treatment.

| Parameter | Baseline | 3 Months | 6 Months | Annually |

| :----------------- | :------- | :--------- | :--------- | :--------- |

| Total Testosterone | X | X | X | X |

| Free Testosterone | X | (Optional) | (Optional) | (Optional) |

| Hematocrit | X | X | X | X |

| PSA | X | | | X (age >40) |

| Lipid Panel | X | | | X |

| Liver Enzymes | X | | | X |

| Bone Mineral Density | X (if indicated) | | | (Every 2-3 yrs if indicated) |

Key Takeaways

TRT may improve mood and reduce depressive symptoms in men with low testosterone, particularly in those with significant hypogonadism and higher-dose regimens.

The evidence for TRT as a treatment for anxiety is less clear and requires further investigation, with some studies showing benefit and others no change or even exacerbation.

TRT may offer modest benefits for certain cognitive functions, especially in older hypogonadal men.

It is essential to consult with a healthcare professional to determine if TRT is an appropriate treatment option, considering individual health status, potential benefits, and risks.

Comprehensive monitoring is critical for safety and efficacy throughout TRT.

References

  • McHenry, J., & Carrier, N. (2019). Sex hormones and the brain: A focus on testosterone. Journal of Neuroendocrinology, 31(2), e12669. [PubMed]
  • Rubinow, D. R., & Schmidt, P. J. (2006). Testosterone and the brain. American Journal of Psychiatry, 163(10), 1681-1683. [PubMed]
  • Borish, C. N., & Gelfand, J. M. (2020). The role of inflammation in mood disorders: A review of the evidence and future directions. Journal of Clinical Psychiatry, 81(2), 19r12918. [PubMed]
  • Kovac, J. R., et al. (2020). Testosterone supplementation and depressive symptoms in men: A systematic review and meta-analysis of placebo-controlled trials. The Lancet Psychiatry, 7(12), 1056-1065. [PubMed]
  • Zarrouf, F. A., et al. (2009). Testosterone and depression: Systematic review and meta-analysis. Journal of Psychiatric Practice, 15(4), 289-305. [PubMed]
  • Shores, M. M., et al. (2013). Testosterone treatment and anxiety in older men with low testosterone levels: a randomized, placebo-controlled clinical trial. Journal of Clinical Endocrinology & Metabolism, 98(10), 4056-4063. [PubMed]
  • Pope, H. G., et al. (2000). Adverse psychiatric effects of anabolic-androgenic steroids: a controlled study of 160 athletes. *Archives of
  • ---

    Related Articles

  • Anastrozole: Complete Guide
  • Anastrozole: Dosing And Protocols
  • Anastrozole: Evidence-Based Review
  • Anastrozole On Trt: Complete Evidence-Based Guide